David Boyer, M.D.
Dr. Boyer is a world-renowned clinician, surgeon and educator. His areas of specialty include the treatment of diseases of the retina and vitreous. He is currently a leading investigator for various national clinical trials on retinal diseases and serves as an advisor for multiple research, educational and charitable institutions. He received a B.S. from the University of Illinois at Champaign, after which he completed a medical degree at the Chicago Medical School. In 1976 he finished his residency at the U.S.C. County Medical Center. Subsequently, he completed a year long retinal surgery fellowship at the Wills Eye Hospital, located in Philadelphia.Close
Carl D. Regillo, MD, FACS
Dr. Regillo is Professor of Ophthalmology at the Sidney Kimmel Medical College at Thomas Jefferson University, Chief of the Retina Service at Wills Eye Hospital and founder and former director of the Wills Eye Clinical Retina Research Unit in Philadelphia. He received his medical degree from Harvard Medical School and performed his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital. He has been the principal investigator of numerous major clinical trials developing new medical and surgical treatments for retinal disorders such as macular degeneration and diabetic retinopathy and has authored more than 200 publications along with over 30 book chapters and nine major books. He is invited to lecture worldwide and serves on the scientific editorial board for several top ophthalmology peer-reviewed journals. As a recognized leader in the field, he is a recipient of many national and international awards, including the American Academy of Ophthalmology Achievement, Senior Achievement, Secretariat, and Lifetime Achievement Awards and the American Society of Retinal Specialists Honor and Senior Honor Awards. He was also selected as a Charter Inductee of the Retina Hall of Fame and named to the Ophthalmologist Power List (Top 100 most influential people in the world of ophthalmology).Close
Mark Pennesi, MD, PhD
Dr. Pennesi is an Associate Professor of Ophthalmology at the Oregon Health & Science University (OHSU) School of Medicine and Division Chief of the Ophthalmic Genetics Service at the OHSU Casey Eye Institute. Since joining the OHSU faculty, Dr. Pennesi has been a principal investigator on many first-in-human clinical trials including for: LCA Type II and Type 10, Usher Syndrome Type IB and 2A, Stargardt disease, X-linked Retinoschisis, X-Linked retinitis pigmentosa and achromatopsia. Dr. Pennesi pursued combined at MD/PhD at Baylor College of Medicine in Houston, Texas and residency in Ophthalmology at University of California – San Francisco, followed by an Ophthalmic Genetics Fellowship at Casey Eye Institute.Close
Geeta Lalwani, M.D.
Dr. Lalwani is the founder of Rocky Mountain Retina Associates, where she specializes in the medical and surgical treatment of retinal diseases. Prior to founding Rocky Mountain Retina, Dr. Lalwani served as an Assistant Professor of Clinical Ophthalmology at the University of Miami’s prestigious Bascom Palmer Eye Institute. Dr. Lalwani completed her fellowship in vitreoretinal surgery at the Bascom Palmer Eye Institute, and ophthalmology residency at Case Western Reserve, and received her M.D. from Drexel University. Dr. Lalwani is Board Certified by the American Board of Ophthalmology. She is a member of the American Academy of Ophthalmologists, American Society of Retina Specialists, the Vit-Buckle Society, EnVision Summit and the esteemed Retina Society.Close